Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study.
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according ...
Inhalers prescribed for asthma, such as albuterol, salmeterol, and arformoterol, can trigger tremors as a side effect. Meanwhile, anti-seizure medications can cause tremors due to their effect on ...
New medical therapies are needed to improve walking performance and to prevent the adverse outcomes associated with PAD-related functional impairment such as mobility loss and the ability to continue ...